We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Solulink Completes Equity Financing for HybriLink™ Antibody-Labeling Technology

News   Jul 19, 2013

 
Solulink Completes Equity Financing for HybriLink™ Antibody-Labeling Technology
 
 
 

RELATED ARTICLES

Zika Study May "Supercharge" Vaccine Research

News

Scientists looking at the genetics of Zika virus have found a way to fast-track research which could lead to new vaccines.

READ MORE

Meningitis Changes Immune Cell Makeup in the Mouse Brain Lining

News

NIH study finds new cell composition may lead to less effective future response.

READ MORE

Device Would Allow TB Dosing to Switch From Daily to Monthly

News

A drug delivery device is under development, which works by slowly releasing antibiotics directly into the patient's stomach. This would allow patients to switch from daily to monthly doses, reducing the burden of tuberculosis treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE